Wang et al. showed that synapsin-promoted Cav-1 gene therapy was able to maintain neuronal and synaptic morphology and preserve hippocampal function such as memory and learning in mice with Alzheimer's disease (97). Here, CAV1 is linked to Alzheimer disease.